<DOC>
	<DOCNO>NCT01046448</DOCNO>
	<brief_summary>Children adolescents chronic kidney disease ( CKD ) high risk cardiovascular ( CV ) morbidity mortality . Recent study suggest pediatric patient even moderately impaired kidney function may afflict significant early cardiac vascular abnormality . The pathogenesis natural course CV comorbidity pediatric CKD patient still elusive . In multicenter , prospective , observational study prevalence , degree progression CV comorbidity child characterize related CKD progression . The morphology function heart vessel monitor sensitive , non-invasive method compare age matched healthy control . Multiple potential clinical , anthropometric , biochemical , pharmacological risk factor monitor prospectively relate CV status . Genotyping might identify predispose genetic factor progression CV comorbidity underlie nephropathy .</brief_summary>
	<brief_title>The Cardiovascular Comorbidity Children With Chronic Kidney Disease Study</brief_title>
	<detailed_description>Adult patient CKD markedly increase risk die cardiovascular event . The risk dramatically increase young patient end-stage renal disease , almost likely die cardiovascular cause elderly individual general population . Early morphological functional vascular abnormality detect even adolescent CKD , information prevalence , severity natural course vascular lesion different stage renal failure lack factor predispose early onset rapid progression cardiovascular morbidity still elusive . The pediatric population appear uniquely suit study effect CKD cardiovascular system due virtual absence vascular morbidity relate ageing , diabetes smoke . In order improve understanding cause consequence cardiovascular comorbidity child progressive CKD , consortium pediatric nephrologists Europe join perform long-term prospective observational study follow cardiovascular health child advance successive stage CKD . The 4C Study follow least 625 patient age 6 17 year glomerular filtration rate 10 45 ml/min/1.73 m² 40 pediatric nephrology unit 14 European country . The morphology function heart large artery regularly assess sensitive , non-invasive method finding compare large group healthy child . Multiple potential clinical , anthropometric , biochemical , pharmacological risk factor monitor prospectively related cardiovascular status patient . A whole genome association study perform identify genetic variant associate progression cardio-vascular alteration renal failure .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<criteria>Age 6 17 year GFR 10 45 ml/min/1.73m² ( CKD stage IIIb V ) ; Active systemic vasculitis Diabetes mellitus Renal vascular anomaly Anomalies limbs prevent standardize diagnostic procedure</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Children</keyword>
	<keyword>chronic renal failure</keyword>
	<keyword>chronic kidney disease</keyword>
	<keyword>cardiovascular disease</keyword>
	<keyword>cardiovascular morbidity</keyword>
	<keyword>leave ventricular hypertrophy</keyword>
	<keyword>carotid intima medium thickness</keyword>
	<keyword>arterial stiffness</keyword>
	<keyword>pulse wave velocity</keyword>
	<keyword>augmentation index</keyword>
	<keyword>leave ventricular cardiac function</keyword>
	<keyword>progression</keyword>
	<keyword>genetic risk factor</keyword>
	<keyword>vasculopathy</keyword>
	<keyword>cardiopathy</keyword>
	<keyword>whole genome analysis</keyword>
	<keyword>haplotype analysis</keyword>
	<keyword>SNP-screening</keyword>
</DOC>